We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A report authored by the University of Newcastle, Australia, has claimed
that "questionable" activities exist within that the country's well-established
pharmaceutical R&D sector.
Healthcare product wholesaler Omega Pharma NV has already had interest from
potential buyers of its dental division, according to a report in business daily
L'Echo, which cites chief executive Marc Coucke.
Nine-year-old Killian Owen was the first child to try an experimental leukemia
treatment that was showing promise in adults - but the chance came too late.
Antigenics Inc. today announced that Oncophage(R) (HSPPC-96), an investigational
personalized cancer vaccine, has been granted orphan drug status for the treatment
of renal cell carcinoma (RCC, the most common type of kidney cancer) by the
European Medicines Agency (EMEA).
Biotechnology company Cell
Genesys Inc. said Tuesday that it will eliminate a quarter of its work force
and shut down certain manufacturing facilities as it focuses on developing its
most promising therapies.
Drug producers in Uganda, Tanzania and Zambia have protested
against plans by a regional trade grouping to abandon a 10% tax on imported
pharmaceuticals.